InvestorsHub Logo

RobotDroid

11/30/22 10:39 AM

#540699 RE: underpar71 #540695

This has already been addressed, this guy does not know what he is talking about.

LearningEveryTrade

11/30/22 10:51 AM

#540709 RE: underpar71 #540695

He's Paid. LOL Dr.Wen Disclosures

Patrick Wen, MD, is a member of the Speaker’s Bureau for Merck and Prime Oncology.

Patrick Wen, MD, serves as a consultant/advisory board member for Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics, Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Biogenics, Deciphera, and VBI Vaccines.

Patrick Wen, MD, received research support from Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics, Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Biogenics, Deciphera, and VBI Vaccines.
Bullish
Bullish

Doc logic

11/30/22 11:14 AM

#540741 RE: underpar71 #540695

underpar71,

This voice is like one that attempts to turn good news into bad with quasi “concerns” not shared by those who signed on the journal article and signed off at JAMA. Granted, someone has to speak up at least indirectly for all the jobs being put at risk at big pharma and hedge funds by voicing THEIR “concerns” otherwise how could money ever buy influence and protection through the formation and maintenance of the status quo?; ). Best wishes.

biosectinvestor

11/30/22 11:46 AM

#540752 RE: underpar71 #540695

When a “journalist” tells a doctor the analysis is “post hoc”, he starts from that premise. But we know Adam Feuerstein is presenting the trial to everyone under false pretenses including that this was “post hoc”, so basing a question on a lie, the answer is going to be based on false information and therefore false.